19 May 2013
Keywords: gsk, lamictal, gets, expanded, indication, food, drug
Article | 26 January 2004
The US Food and Drug Administration has cleared GlaxoSmithKline's Lamictal (lamotrigine) as a monotherapy for the treatment of partial
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2004
17 May 2013
© 2013 thepharmaletter.com